Home › Hyperthyroidism
Hyperthyroidism clinical trials recruiting in the U.S.
9 studies for Hyperthyroidism are recruiting participants at sites across the United States.
Thyroid hormones control the rate of many activities in your body. Hyperthyroidism means the thyroid makes more thyroid hormones than the body needs.
Cities with the most studies
- Houston, TX5 studies
- Miami, FL5 studies
- Dallas, TX5 studies
- Washington, DC3 studies
- Hialeah, FL3 studies
- Asheville, NC3 studies
- Wilmington, NC3 studies
- Akron, OH3 studies
- San Antonio, TX3 studies
- San Francisco, CA3 studies
- Torrance, CA3 studies
By state
- Arizona4 studies
- California7 studies
- Florida6 studies
- Georgia4 studies
- Illinois3 studies
- Maryland3 studies
- Michigan3 studies
- New York3 studies
- North Carolina7 studies
- Ohio4 studies
- Pennsylvania4 studies
- Tennessee3 studies
- Texas6 studies
Recently updated studies
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Nov 12, 2026 · NCT07661056A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Nov 12, 2026 · NCT07722546Natural History of Thyroid Function Disorders
RecruitingObservational study
6 Months – 98 Years · All sexes · Updated Nov 12, 2026 · NCT00001159Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT07682896NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Oct 29, 2026 · NCT07305818Evaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye Disease
RecruitingPhase 1Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT07885605A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 25, 2026 · NCT06727604Study of BHV-1300 in Graves' Disease
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Jul 31, 2026 · NCT06980649Evaluating an AI Tool for Detecting Thyrotoxic States
RecruitingObservational study
Ages 22 and older · All sexes · Updated Jun 1, 2026 · NCT07017907From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.